159 related articles for article (PubMed ID: 32170125)
1. Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice.
Luo XL; Lin L; Hu H; Hu FL; Lin Y; Luo ML; Wang L; He YQ
Sci Rep; 2020 Mar; 10(1):4681. PubMed ID: 32170125
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
[TBL] [Abstract][Full Text] [Related]
3. MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis.
Ghosh A; Sarkar S; Banerjee S; Behbod F; Tawfik O; McGregor D; Graff S; Banerjee SK
PLoS One; 2018; 13(5):e0198143. PubMed ID: 29813119
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Adipose and Luminal Mammary Gland Compartment as Orthotopic Inoculation Sites in a 4T1-Based Immunocompetent Preclinical Model for Triple-Negative Breast Cancer.
Steenbrugge J; Breyne K; Denies S; Dekimpe M; Demeyere K; De Wever O; Vermeulen P; Van Laere S; Sanders NN; Meyer E
J Mammary Gland Biol Neoplasia; 2016 Dec; 21(3-4):113-122. PubMed ID: 27714576
[TBL] [Abstract][Full Text] [Related]
5. Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer.
Steenbrugge J; Vander Elst N; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Dirix L; Van Laere S; Meyer E
Front Immunol; 2019; 10():2928. PubMed ID: 31921184
[TBL] [Abstract][Full Text] [Related]
6. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
[TBL] [Abstract][Full Text] [Related]
7. Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis.
Atiya HI; Dvorkin-Gheva A; Hassell J; Patel S; Parker RL; Hartstone-Rose A; Hodge J; Fan D; Ramsdell AF
Anticancer Res; 2019 May; 39(5):2277-2287. PubMed ID: 31092419
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II promotes primary tumor growth and metastasis formation of murine TNBC 4T1 cells through the fibroblasts around cancer cells.
Takiguchi T; Takahashi-Yanaga F; Ishikane S; Tetsuo F; Hosoda H; Arioka M; Kitazono T; Sasaguri T
Eur J Pharmacol; 2021 Oct; 909():174415. PubMed ID: 34375673
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
Lee J; Lim B; Pearson T; Choi K; Fuson JA; Bartholomeusz C; Paradiso LJ; Myers T; Tripathy D; Ueno NT
Breast Cancer Res Treat; 2019 Jun; 175(2):339-351. PubMed ID: 30826934
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced lung metastasis development is MT1-MMP-dependent in a triple-negative breast cancer mouse model.
Bouchard G; Therriault H; Geha S; Bujold R; Saucier C; Paquette B
Br J Cancer; 2017 Feb; 116(4):479-488. PubMed ID: 28103615
[TBL] [Abstract][Full Text] [Related]
11. In vivo magnetic resonance imaging investigating the development of experimental brain metastases due to triple negative breast cancer.
Hamilton AM; Foster PJ
Clin Exp Metastasis; 2017 Feb; 34(2):133-140. PubMed ID: 28108861
[TBL] [Abstract][Full Text] [Related]
12. Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression.
Arroyo-Crespo JJ; Armiñán A; Charbonnier D; Deladriere C; Palomino-Schätzlein M; Lamas-Domingo R; Forteza J; Pineda-Lucena A; Vicent MJ
Int J Cancer; 2019 Oct; 145(8):2267-2281. PubMed ID: 30860605
[TBL] [Abstract][Full Text] [Related]
13. Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1.
Singh M; Ramos I; Asafu-Adjei D; Quispe-Tintaya W; Chandra D; Jahangir A; Zang X; Aggarwal BB; Gravekamp C
Cancer Med; 2013 Aug; 2(4):571-82. PubMed ID: 24156030
[TBL] [Abstract][Full Text] [Related]
14. CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis.
Wu J; Li L; Liu J; Wang Y; Wang Z; Wang Y; Liu W; Zhou Z; Chen C; Liu R; Yang R
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):835-842. PubMed ID: 30032244
[TBL] [Abstract][Full Text] [Related]
15. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
16. Follistatin-like 1 deficiency impairs T cell development to promote lung metastasis of triple negative breast cancer.
Ma J; Yang Y; Wang L; Jia X; Lu T; Zeng Y; Liu L; Gao Y
Aging (Albany NY); 2021 Feb; 13(5):7211-7227. PubMed ID: 33639614
[TBL] [Abstract][Full Text] [Related]
17. Cripto-1 as a novel therapeutic target for triple negative breast cancer.
Castro NP; Fedorova-Abrams ND; Merchant AS; Rangel MC; Nagaoka T; Karasawa H; Klauzinska M; Hewitt SM; Biswas K; Sharan SK; Salomon DS
Oncotarget; 2015 May; 6(14):11910-29. PubMed ID: 26059540
[TBL] [Abstract][Full Text] [Related]
18. Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model.
Cranford TL; Velázquez KT; Enos RT; Bader JE; Carson MS; Chatzistamou I; Nagarkatti M; Murphy EA
Cancer Biol Ther; 2017 Feb; 18(2):85-93. PubMed ID: 28075192
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of triple negative breast cancer cell migration and metastases formation is prevented by chloroquine in a pre-irradiated mouse model.
Bouchard G; Therriault H; Geha S; Bérubé-Lauzière Y; Bujold R; Saucier C; Paquette B
BMC Cancer; 2016 Jun; 16():361. PubMed ID: 27282478
[TBL] [Abstract][Full Text] [Related]
20. Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
Aprelikova O; Tomlinson CC; Hoenerhoff M; Hixon JA; Durum SK; Qiu TH; He S; Burkett S; Liu ZY; Swanson SM; Green JE
PLoS One; 2016; 11(5):e0155262. PubMed ID: 27171183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]